Transplant Diagnostics Market by Product & Service, Technology, Application, Type, End User & Region - Global Forecast to 2031

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Stakeholders
1.6 Summary of Changes

2.1 Key Insights & Market Highlights
2.2 Key Market Participants: Insights & Strategic Developments
2.3 Disruptive Trends Shaping Market Growth
2.4 High-Growth Segments & Emerging Frontiers
2.5 Snapshot: Global Market Size, Growth Rate, and Forecast

3.1 Transplant Diagnostics Market Overview
3.2 Transplant Diagnostics Market, by Product & Service, 2026 Vs. 2031
3.3 Transplant Diagnostics Market, by Technology, 2026 Vs. 2031
3.4 Transplant Diagnostics Market, by Application, 2026 Vs. 2031
3.5 Transplant Diagnostics Market, by Type, 2026 Vs. 2031
3.6 Transplant Diagnostics Market, by End User, 2026 Vs. 2031
3.7 Transplant Diagnostics Market: Geographic Growth Opportunities

4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Increasing Number of Transplant Procedures
4.2.1.2 Advancements in Molecular Diagnostic Technologies
4.2.1.3 Increasing Public-Private Funding For Transplant Research
4.2.1.4 Rising Incidence of Chronic Diseases
4.2.2 Restraints
4.2.2.1 High Cost of Instruments and Consumables
4.2.2.2 Limited Access to Advanced Transplant Diagnostic Infrastructure in Emerging Economies
4.2.3 Opportunities
4.2.3.1 Increasing Adoption of Cross-Matching and Chimerism Testing
4.2.3.2 Growing Awareness Regarding Organ Donation and Transplantation
4.2.4 Challenges
4.2.4.1 Gap Between Organ Donor Availability and Transplant Demand
4.3 Unmet Needs & White Spaces
4.3.1 Unmet Needs in Transplant Diagnostics Market
4.3.2 White Space Opportunities
4.4 Interconnected Markets & Cross-Sector Opportunities
4.4.1 Interconnected Markets
4.4.2 Cross-Sector Opportunities
4.5 Strategic Moves by Tier 1/2/3 Players
4.5.1 Key Moves & Strategic Focus

5.1 Porter'S Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Competitive Rivalry
5.2 Macroeconomic Indicators
5.2.1 Introduction
5.2.2 GDP Trends & Forecast
5.3 Supply Chain Analysis
5.4 Value Chain Analysis
5.5 Ecosystem Analysis
5.6 Pricing Analysis
5.6.1 Average Selling Price Trend of Transplant Diagnostic Products, by Key Player, 2024-2026
5.6.2 Average Selling Price Trend of Transplant Diagnostic Products, by Region, 2024-2026
5.7 Trade Analysis
5.7.1 Import Scenario (Hs Code 3822)
5.7.2 Export Scenario (Hs Code 3822)
5.8 Key Conferences & Events, 2026-2027
5.9 Trends/Disruptions Impacting Customers’ Businesses
5.10 Investment & Funding Scenario
5.11 Impact of 2025 US Tariffs On Transplant Diagnostics Market
5.11.1 Introduction
5.11.2 Key Tariff Rates
5.11.3 Price Impact Analysis
5.11.4 Impact On Region
5.11.4.1 North America
5.11.4.2 Europe
5.11.4.3 Asia-Pacific
5.11.5 Impact On End-Use Industries
5.11.5.1 Hospitals & Transplant Centers
5.11.5.2 Research & Academic Institutes
5.11.5.3 Independent Reference Laboratories

6.1 Key Emerging Technologies
6.1.1 Donor-Derived Cell-Free Dna (Dd-Cfdna)
6.1.2 Digital Pcr (Dpcr)
6.2 Complementary Technologies
6.2.1 AI in Transplant Diagnostics
6.2.2 Bioinformatics
6.3 Adjacent Technologies
6.3.1 Liquid Biopsy
6.3.2 Digital Pathology
6.4 Technology/Product Roadmap
6.5 Patent Analysis
6.5.1 List of Key Patents
6.6 Future Applications
6.7 Impact of AI/Generative AI On Transplant Diagnostics Market
6.7.1 Introduction
6.7.2 Top Use Cases & Market Potential
6.7.3 Key Companies Implementing AI
6.7.4 Future of AI

7.1 Regional Regulations & Compliance
7.1.1 Regulatory Bodies, Government Agencies, and Other Organizations
7.2 Sustainability Initiatives
7.2.1 Environmental Impact & Eco-Friendly Initiatives in Transplant Diagnostics
7.2.1.1 Eco-Friendly Initiatives
7.3 Sustainability Impact & Regulatory Policy Initiatives

8.1 Decision-Making Process
8.2 Buyer Stakeholders & Buying Evaluation Criteria
8.2.1 Key Stakeholders in Buying Process
8.2.2 Buying Criteria
8.3 Adoption Barriers & Internal Challenges
8.4 Unmet Needs in Various End-Use Industries
8.5 Market Profitability
8.5.1 Revenue Potential
8.5.2 Cost Dynamics
8.5.3 Margin Opportunities in Key Applications

9.1 Introduction
9.2 Reagents & Consumables
9.2.1 Reagents & Consumables to Be Largest and Fastest-Growing Segment in Transplant Diagnostics Market
9.3 Instruments
9.3.1 Increasing Public-Private Investments to Drive Market
9.4 Software & Services
9.4.1 Growing Automation & Digitalization of Diagnostic Laboratory Procedures to Support Market Growth

10.1 Introduction
10.2 Molecular Assays
10.2.1 Pcr-Based Molecular Assays
10.2.1.1 Real-Time Pcr
10.2.1.1.1 Smaller Sample Volume Requirements Compared to Conventional Pcr Technologies to Drive Demand
10.2.1.2 Sequence-Specific Primer-Pcr (Ssp-Pcr)
10.2.1.2.1 Growing Public-Private Investments For Research Activities to Support Market Growth
10.2.1.3 Sequence-Specific Oligonucleotide-Pcr (Sso-Pcr)
10.2.1.3.1 Wide Adoption of Technique in Pcr-Based Molecular Assays Market to Fuel Growth
10.2.1.4 Other Pcr-Based Molecular Assays
10.2.2 Sequencing-Based Molecular Assays
10.2.2.1 Sanger Sequencing
10.2.2.1.1 Growing Demand For High-Throughput Dna Sequencers in Transplant Diagnostic Applications to Drive Market
10.2.2.2 Next-Generation Sequencing (Ngs)
10.2.2.2.1 Low Turnaround Time and High-Throughput Sequencing to Drive Adoption of Ngs
10.2.2.3 Other Sequencing-Based Molecular Assays
10.3 Non-Molecular Assays
10.3.1 Replacement of Non-Molecular Assay Techniques With Dna-Based Techniques to Hamper Growth

11.1 Introduction
11.2 Diagnostic Applications
11.2.1 Pre-Transplantation Diagnostics
11.2.1.1 Infectious Disease Testing
11.2.1.1.1 Growing Adoption of Advanced Molecular Techniques For Pathogen Detection to Drive Market
11.2.1.2 Histocompatibility Testing
11.2.1.2.1 Technological Advancements and Growing R&D Activities to Propel Market
11.2.1.3 Blood Profiling
11.2.1.3.1 Growing Availability of Molecular Assay Products to Support Market Growth
11.2.2 Post-Transplantation Diagnostics
11.2.2.1 Greater Risk of Disorders and Infections Post-Transplantation to Make Diagnostics Necessary Step
11.3 Research Applications
11.3.1 Growing Funding For Research to Drive Market

12.1 Introduction
12.2 Solid Organ Transplantation
12.2.1 Kidney Transplantation
12.2.1.1 Rising Prevalence of Kidney Diseases to Drive Market
12.2.2 Liver Transplantation
12.2.2.1 Growing Patient Population With Chronic Liver Diseases and Increasing Procedural Volume to Drive Market
12.2.3 Lung Transplantation
12.2.3.1 Rising Prevalence of Chronic Lung Diseases to Drive Market
12.2.4 Heart Transplantation
12.2.4.1 Increasing Prevalence of Chronic Cardiac Diseases to Propel Market
12.2.5 Pancreas Transplantation
12.2.5.1 Procedural Complexity and Risk of Surgical Complications to Restrain Growth
12.2.6 Other Solid Organ Transplantation
12.3 Stem Cell Transplantation
12.3.1 Rising Procedural Volume and Growing Research Activities to Drive Market
12.4 Soft Tissue Transplantation
12.4.1 Technological Advancements and Rising Prevalence of Target Diseases to Drive Market
12.5 Bone Marrow Transplantation
12.5.1 Dearth of Well-Trained Surgeons to Perform Bone Marrow Transplantation to Hinder Growth

13.1 Introduction
13.2 Independent Reference Laboratories
13.2.1 Rising Consolidation of Diagnostic Laboratories to Drive Market
13.3 Hospitals & Transplant Centers
13.3.1 Growing Purchasing Power of Hospitals & Transplant Centers to Support Market Growth
13.4 Research Laboratories & Academic Institutes
13.4.1 Increasing Industry-Academia Collaborations in Genomics-Based Transplant Diagnostic Research to Drive Market

14.1 Introduction
14.2 North America
14.2.1 US
14.2.1.1 Growing Organ Transplantation Activity to Support Market Expansion
14.2.2 Canada
14.2.2.1 Growing Transplant Programs to Support Market Growth
14.3 Europe
14.3.1 Germany
14.3.1.1 Expanding Donor Registry Network to Fuel Market Growth
14.3.2 UK
14.3.2.1 Rising Transplant Demand to Support Market Growth
14.3.3 France
14.3.3.1 Growing Organ Donation Initiatives to Drive Growth
14.3.4 Italy
14.3.4.1 Increasing Organ Donation Rates to Drive Market Growth
14.3.5 Spain
14.3.5.1 Strong Organ Donation System to Support Market Growth
14.3.6 Rest of Europe
14.4 Asia-Pacific
14.4.1 China
14.4.1.1 Expanding Transplantation Programs to Drive Market Growth
14.4.2 Japan
14.4.2.1 Growing Transplant Waiting Population to Support Market Growth
14.4.3 India
14.4.3.1 Rising Transplant Procedures to Drive Market Growth
14.4.4 Australia
14.4.4.1 Rising Number of Solid Organ Transplantation Procedures to Drive Market
14.4.5 South Korea
14.4.5.1 Large Transplant Waiting Population to Drive Market Growth
14.4.6 Rest of Asia-Pacific
14.5 Latin America
14.5.1 Brazil
14.5.1.1 Expanding Transplant Programs to Drive Market Growth
14.5.2 Mexico
14.5.2.1 Growing Medical Tourism to Support Market Growth
14.5.3 Rest of Latin America
14.6 Middle East & Africa
14.6.1 UAE
14.6.1.1 Expanding Organ Donation Programs to Drive Market Growth
14.6.2 Saudi Arabia
14.6.2.1 Strengthening Transplantation Capabilities to Support Market Growth
14.6.3 Rest of Middle East & Africa
14.6.4 US: Heart, Liver, and Lung Transplants Market Volume

15.1 Introduction
15.2 Key Player Strategies/Right to Win
15.2.1 Overview of Strategies Deployed by Players in Transplant Diagnostics Market
15.3 Revenue Analysis, 2023-2025
15.4 Market Share Analysis, 2025
15.4.1 Global Market Share Analysis, 2025
15.5 Company Evaluation Matrix: Key Players, 2025
15.5.1 Stars
15.5.2 Emerging Leaders
15.5.3 Pervasive Players
15.5.4 Participants
15.5.5 Company Footprint: Key Players, 2025
15.5.5.1 Company Footprint
15.5.5.2 Region Footprint
15.5.5.3 Product & Service Footprint
15.5.5.4 Application Footprint
15.5.5.5 End-User Footprint
15.6 Company Evaluation Matrix: Startups/SMEs, 2025
15.6.1 Progressive Companies
15.6.2 Responsive Companies
15.6.3 Dynamic Companies
15.6.4 Starting Blocks
15.6.5 Company Evaluation Matrix: Startups/SMEs, 2025
15.6.5.1 Detailed List of Key Startups/SMEs
15.6.5.2 Competitive Benchmarking of Startups/SMEs (1/2)
15.6.5.3 Competitive Benchmarking of Startups/SMEs (2/2)
15.7 Company Valuation & Financial Metrics
15.7.1 Financial Metrics
15.7.2 Company Valuation
15.8 Brand/Product Comparison
15.9 Competitive Scenario
15.9.1 Product/Service Launches & Approvals
15.9.2 Deals
15.9.3 Expansions

16.1 Key Players
16.1.1 Thermo Fisher Scientific Inc.
16.1.1.1 Business Overview
16.1.1.2 Products Offered
16.1.1.3 Recent Developments
16.1.1.3.1 Product & Service Launches
16.1.1.3.2 Deals
16.1.1.3.3 Expansions
16.1.1.4 Analyst's View
16.1.1.4.1 Right to Win
16.1.1.4.2 Strategic Choices
16.1.1.4.3 Weaknesses & Competitive Threats
16.1.2 F. Hoffmann-La Roche Ltd.
16.1.2.1 Business Overview
16.1.2.2 Products Offered
16.1.2.3 Recent Developments
16.1.2.3.1 Product Launches & Approvals
16.1.2.3.2 Deals
16.1.2.4 Analyst's View
16.1.2.4.1 Right to Win
16.1.2.4.2 Strategic Choices
16.1.2.4.3 Weaknesses & Competitive Threats
16.1.3 Bio-Rad Laboratories, Inc.
16.1.3.1 Business Overview
16.1.3.2 Products Offered
16.1.3.3 Recent Developments
16.1.3.3.1 Product Launches
16.1.3.3.2 Deals
16.1.3.4 Analyst's View
16.1.3.4.1 Right to Win
16.1.3.4.2 Strategic Choices
16.1.3.4.3 Weaknesses & Competitive Threats
16.1.4 Qiagen N.V.
16.1.4.1 Business Overview
16.1.4.2 Products Offered
16.1.4.3 Recent Developments
16.1.4.3.1 Product Launches & Approvals
16.1.4.3.2 Deals
16.1.4.4 Analyst's View
16.1.4.4.1 Right to Win
16.1.4.4.2 Strategic Choices
16.1.4.4.3 Weaknesses & Competitive Threats
16.1.5 Biomérieux
16.1.5.1 Business Overview
16.1.5.2 Products Offered
16.1.5.3 Recent Developments
16.1.5.3.1 Product Launches & Approvals
16.1.5.3.2 Deals
16.1.5.4 Analyst's View
16.1.5.4.1 Right to Win
16.1.5.4.2 Strategic Choices
16.1.5.4.3 Weaknesses & Competitive Threats
16.1.6 Illumina, Inc.
16.1.6.1 Business Overview
16.1.6.2 Products Offered
16.1.6.3 Recent Developments
16.1.6.3.1 Deals
16.1.7 Becton, Dickinson and Company
16.1.7.1 Business Overview
16.1.7.2 Products Offered
16.1.7.3 Recent Developments
16.1.7.3.1 Deals
16.1.8 Caredx, Inc.
16.1.8.1 Business Overview
16.1.8.2 Products Offered
16.1.8.3 Recent Developments
16.1.8.3.1 Product Launches
16.1.8.3.2 Deals
16.1.9 Diasorin S.P.A.
16.1.9.1 Business Overview
16.1.9.2 Products Offered
16.1.9.3 Recent Developments
16.1.9.3.1 Product Launches
16.1.9.3.2 Deals
16.1.10 Werfen
16.1.10.1 Business Overview
16.1.10.2 Products Offered
16.1.10.3 Recent Developments
16.1.10.3.1 Product Launches
16.1.10.3.2 Deals
16.1.11 Merck Kgaa
16.1.11.1 Business Overview
16.1.11.2 Products Offered
16.1.11.3 Recent Developments
16.1.11.3.1 Deals
16.1.11.3.2 Expansions
16.1.12 Hologic, Inc.
16.1.12.1 Business Overview
16.1.12.2 Products Offered
16.2 Other Players
16.2.1 Eurobio Scientific
16.2.2 Biofortuna Limited
16.2.3 Bag Diagnostics GmbH
16.2.4 Fujirebio
16.2.5 Histogenetics LLC
16.2.6 Pacbio
16.2.7 Tbg Biotechnology Corp
16.2.8 Scisco Genetics, Inc.
16.2.9 Inno-Train Diagnostik GmbH
16.2.10 Bionobis
16.2.11 Takara Bio Inc.
16.2.12 Krishgen Biosystems Private Limited
16.2.13 Proimmune Ltd.

17.1 Research Data
17.1.1 Secondary Data
17.1.1.1 List of Secondary Sources
17.1.1.2 Key Data From Secondary Sources
17.1.2 Primary Data
17.1.2.1 List of Primary Sources
17.1.2.2 Key Data From Primary Sources
17.1.2.3 Key Industry Insights
17.1.2.4 Breakdown of Primary Interviews
17.2 Market Size Estimation
17.2.1 Total Market Size: Transplant Diagnostics Market
17.2.2 Bottom-Up Approach
17.2.2.1 Approach 1: Revenue Estimation of Key Players
17.2.2.2 Approach 2: Study of Annual Reports and Investor Presentations
17.2.2.3 Approach 3: Primary Interviews
17.2.2.4 Growth Forecast
17.2.2.5 Cagr Projections
17.2.3 Top-Down Approach
17.3 Data Triangulation
17.4 Research Assumptions
17.4.1 Study-Related Assumptions
17.5 Study Assumptions
17.5.1 Parametric Assumptions
17.5.2 Growth Rate Assumptions
17.6 Research Limitations
17.7 Risk Assessment

18.1 Discussion Guide
18.2 Knowledgestore: The Subscription Portal
18.3 Customization Options
18.4 Related Reports
18.5 Author Details

Table 1 Transplant Diagnostics Market: Porter'S Five Forces Analysis
Table 2 GDP Percentage Change (%), by Key Country, 2023-2030
Table 3 North America: Macroeconomic Indicators
Table 4 Europe: Macroeconomic Indicators
Table 5 Asia-Pacific: Macroeconomic Indicators
Table 6 Latin America: Macroeconomic Indicators
Table 7 Middle East & Africa: Macroeconomic Indicators
Table 8 Transplant Diagnostics Market: Role of Companies in Ecosystem
Table 9 Average Selling Price Trend of Transplant Diagnostic Products, by Key Player, 2024-2026 (USD)
Table 10 Average Selling Price Trend of Transplant Diagnostic Products, by Region, 2024-2026 (USD)
Table 11 Import Data For Hs Code 3822-Compliant Products, by Country, 2021-2025 (USD Million)
Table 12 Export Data For Hs Code 3822-Compliant Products, by Country, 2021-2025 (USD Million)
Table 13 Transplant Diagnostics Market: Key Conferences & Events, 2026-2027
Table 14 US-Adjusted Reciprocal Tariff Rates
Table 15 Key Patents in Transplant Diagnostics Market, 2022-2026
Table 16 Key Companies Implementing AI in Transplant Diagnostics Market
Table 17 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 18 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 19 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 20 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 21 Rest of the World: Regulatory Bodies, Government Agencies, and Other Organizations
Table 22 Influence of Stakeholders On Buying Process, by Product & Service (%)
Table 23 Key Buying Criteria, by Product & Service
Table 24 Adoption Barriers & Internal Challenges
Table 25 Transplant Diagnostics Market: Unmet Needs in Various End-Use Industries
Table 26 Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 27 Transplant Diagnostics Market For Reagents & Consumables, by Region, 2024-2031 (USD Million)
Table 28 North America: Transplant Diagnostics Market For Reagents & Consumables, by Country, 2024-2031 (USD Million)
Table 29 Europe: Transplant Diagnostics Market For Reagents & Consumables, by Country, 2024-2031 (USD Million)
Table 30 Asia-Pacific: Transplant Diagnostics Market For Reagents & Consumables, by Country, 2024-2031 (USD Million)
Table 31 Latin America: Transplant Diagnostics Market For Reagents & Consumables, by Country, 2024-2031 (USD Million)
Table 32 Middle East & Africa: Transplant Diagnostics Market For Reagents & Consumables, by Country, 2024-2031 (USD Million)
Table 33 Transplant Diagnostics Market For Instruments, by Region, 2024-2031 (USD Million)
Table 34 North America: Transplant Diagnostics Market For Instruments, by Country, 2024-2031 (USD Million)
Table 35 Europe: Transplant Diagnostics Market For Instruments, by Country, 2024-2031 (USD Million)
Table 36 Asia-Pacific: Transplant Diagnostics Market For Instruments, by Country, 2024-2031 (USD Million)
Table 37 Latin America: Transplant Diagnostics Market For Instruments, by Country, 2024-2031 (USD Million)
Table 38 Middle East & Africa: Transplant Diagnostics Market For Instruments, by Country, 2024-2031 (USD Million)
Table 39 Transplant Diagnostics Market For Software & Services, by Region, 2024-2031 (USD Million)
Table 40 North America: Transplant Diagnostics Market For Software & Services, by Country, 2024-2031 (USD Million)
Table 41 Europe: Transplant Diagnostics Market For Software & Services, by Country, 2024-2031 (USD Million)
Table 42 Asia-Pacific: Transplant Diagnostics Market For Software & Services, by Country, 2024-2031 (USD Million)
Table 43 Latin America: Transplant Diagnostics Market For Software & Services, by Country, 2024-2031 (USD Million)
Table 44 Middle East & Africa: Transplant Diagnostics Market For Software & Services, by Country, 2024-2031 (USD Million)
Table 45 Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 46 Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 47 Transplant Diagnostics Market For Molecular Assays, by Region, 2024-2031 (USD Million)
Table 48 North America: Transplant Diagnostics Market For Molecular Assays, by Country, 2024-2031 (USD Million)
Table 49 Europe: Transplant Diagnostics Market For Molecular Assays, by Country, 2024-2031 (USD Million)
Table 50 Asia-Pacific: Transplant Diagnostics Market For Molecular Assays, by Country, 2024-2031 (USD Million)
Table 51 Latin America: Transplant Diagnostics Market For Molecular Assays, by Country, 2024-2031 (USD Million)
Table 52 Middle East & Africa: Transplant Diagnostics Market For Molecular Assays, by Country, 2024-2031 (USD Million)
Table 53 Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 54 Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Region, 2024-2031 (USD Million)
Table 55 North America: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 56 Europe: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 57 Asia-Pacific: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 58 Latin America: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 59 Middle East & Africa: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 60 Transplant Diagnostics Market For Real-Time Pcr, by Region, 2024-2031 (USD Million)
Table 61 North America: Transplant Diagnostics Market For Real-Time Pcr, by Country, 2024-2031 (USD Million)
Table 62 Europe: Transplant Diagnostics Market For Real-Time Pcr, by Country, 2024-2031 (USD Million)
Table 63 Asia-Pacific: Transplant Diagnostics Market For Real-Time Pcr, by Country, 2024-2031 (USD Million)
Table 64 Latin America: Transplant Diagnostics Market For Real-Time Pcr, by Country, 2024-2031 (USD Million)
Table 65 Middle East & Africa: Transplant Diagnostics Market For Real-Time Pcr, by Country, 2024-2031 (USD Million)
Table 66 Transplant Diagnostics Market For Sequence-Specific Primer-Pcr, by Region, 2024-2031 (USD Million)
Table 67 North America: Transplant Diagnostics Market For Sequence-Specific Primer-Pcr, by Country, 2024-2031 (USD Million)
Table 68 Europe: Transplant Diagnostics Market For Sequence-Specific Primer-Pcr, by Country, 2024-2031 (USD Million)
Table 69 Asia-Pacific: Transplant Diagnostics Market For Sequence-Specific Primer-Pcr, by Country, 2024-2031 (USD Million)
Table 70 Latin America: Transplant Diagnostics Market For Sequence-Specific Primer-Pcr, by Country, 2024-2031 (USD Million)
Table 71 Middle East & Africa: Transplant Diagnostics Market For Sequence-Specific Primer-Pcr, by Country, 2024-2031 (USD Million)
Table 72 Transplant Diagnostics Market For Sequence-Specific Oligonucleotide-Pcr, by Region, 2024-2031 (USD Million)
Table 73 North America: Transplant Diagnostics Market For Sequence-Specific Oligonucleotide-Pcr, by Country, 2024-2031 (USD Million)
Table 74 Europe: Transplant Diagnostics Market For Sequence-Specific Oligonucleotide-Pcr, by Country, 2024-2031 (USD Million)
Table 75 Asia-Pacific: Transplant Diagnostics Market For Sequence-Specific Oligonucleotide-Pcr, by Country, 2024-2031 (USD Million)
Table 76 Latin America: Transplant Diagnostics Market For Sequence-Specific Oligonucleotide-Pcr, by Country, 2024-2031 (USD Million)
Table 77 Middle East & Africa: Transplant Diagnostics Market For Sequence-Specific Oligonucleotide-Pcr, by Country, 2024-2031 (USD Million)
Table 78 Transplant Diagnostics Market For Other Pcr-Based Molecular Assays, by Region, 2024-2031 (USD Million)
Table 79 North America: Transplant Diagnostics Market For Other Pcr-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 80 Europe: Transplant Diagnostics Market For Other Pcr-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 81 Asia-Pacific: Transplant Diagnostics Market For Other Pcr-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 82 Latin America: Transplant Diagnostics Market For Other Pcr-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 83 Middle East & Africa: Transplant Diagnostics Market For Other Pcr-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 84 Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 85 Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Region, 2024-2031 (USD Million)
Table 86 North America: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 87 Europe: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 88 Asia-Pacific: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 89 Latin America: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 90 Middle East & Africa: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 91 Transplant Diagnostics Market For Sanger Sequencing, by Region, 2024-2031 (USD Million)
Table 92 North America: Transplant Diagnostics Market For Sanger Sequencing, by Country, 2024-2031 (USD Million)
Table 93 Europe: Transplant Diagnostics Market For Sanger Sequencing, by Country, 2024-2031 (USD Million)
Table 94 Asia-Pacific: Transplant Diagnostics Market For Sanger Sequencing, by Country, 2024-2031 (USD Million)
Table 95 Latin America: Transplant Diagnostics Market For Sanger Sequencing, by Country, 2024-2031 (USD Million)
Table 96 Middle East & Africa: Transplant Diagnostics Market For Sanger Sequencing, by Country, 2024-2031 (USD Million)
Table 97 Transplant Diagnostics Market For Next-Generation Sequencing, by Region, 2024-2031 (USD Million)
Table 98 North America: Transplant Diagnostics Market For Next-Generation Sequencing, by Country, 2024-2031 (USD Million)
Table 99 Europe: Transplant Diagnostics Market For Next-Generation Sequencing, by Country, 2024-2031 (USD Million)
Table 100 Asia-Pacific: Transplant Diagnosticsarket For Next-Generation Sequencing, by Country, 2024-2031 (USD Million)
Table 101 Latin America: Transplant Diagnostics Market For Next-Generation Sequencing, by Country, 2024-2031 (USD Million)
Table 102 Middle East & Africa: Transplant Diagnostics Market For Next-Generation Sequencing, by Country, 2024-2031 (USD Million)
Table 103 Transplant Diagnostics Market For Other Sequencing-Based Molecular Assays, by Region, 2024-2031 (USD Million)
Table 104 North America: Transplant Diagnostics Market For Other Sequencing-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 105 Europe: Transplant Diagnostics Market For Other Sequencing-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 106 Asia-Pacific: Transplant Diagnostics Market For Other Sequencing-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 107 Latin America: Transplant Diagnostics Market For Other Sequencing-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 108 Middle East & Africa: Transplant Diagnostics Market For Other Sequencing-Based Molecular Assays, by Country, 2024-2031 (USD Million)
Table 109 Transplant Diagnostics Market For Non-Molecular Assays, by Region, 2024-2031 (USD Million)
Table 110 North America: Transplant Diagnostics Market For Non-Molecular Assays, by Country, 2024-2031 (USD Million)
Table 111 Europe: Transplant Diagnostics Market For Non-Molecular Assays, by Country, 2024-2031 (USD Million)
Table 112 Asia-Pacific: Transplant Diagnostics Market For Non-Molecular Assays, by Country, 2024-2031 (USD Million)
Table 113 Latin America: Transplant Diagnostics Market For Non-Molecular Assays, by Country, 2024-2031 (USD Million)
Table 114 Middle East & Africa: Transplant Diagnostics Market For Non-Molecular Assays, by Country, 2024-2031 (USD Million)
Table 115 Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 116 Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 117 Transplant Diagnostics Market For Diagnostic Applications, by Region, 2024-2031 (USD Million)
Table 118 North America: Transplant Diagnostics Market For Diagnostic Applications, by Country, 2024-2031 (USD Million)
Table 119 Europe: Transplant Diagnostics Market For Diagnostic Applications, by Country, 2024-2031 (USD Million)
Table 120 Asia-Pacific: Transplant Diagnostics Market For Diagnostic Applications, by Country, 2024-2031 (USD Million)
Table 121 Latin America: Transplant Diagnostics Market For Diagnostic Applications, by Country, 2024-2031 (USD Million)
Table 122 Middle East & Africa: Transplant Diagnostics Market For Diagnostic Applications, by Country, 2024-2031 (USD Million)
Table 123 Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 124 Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Region, 2024-2031 (USD Million)
Table 125 North America: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Country, 2024-2031 (USD Million)
Table 126 Europe: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Country, 2024-2031 (USD Million)
Table 127 Asia-Pacific: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Country, 2024-2031 (USD Million)
Table 128 Latin America: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Country, 2024-2031 (USD Million)
Table 129 Middle East & Africa: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Country, 2024-2031 (USD Million)
Table 130 Transplant Diagnostics Market For Infectious Disease Testing, by Region, 2024-2031 (USD Million)
Table 131 North America: Transplant Diagnostics Market For Infectious Disease Testing, by Country, 2024-2031 (USD Million)
Table 132 Europe: Transplant Diagnostics Market For Infectious Disease Testing, by Country, 2024-2031 (USD Million)
Table 133 Asia-Pacific: Transplant Diagnostics Market For Infectious Disease Testing, by Country, 2024-2031 (USD Million)
Table 134 Latin America: Transplant Diagnostics Market For Infectious Disease Testing, by Country, 2024-2031 (USD Million)
Table 135 Middle East & Africa: Transplant Diagnostics Market For Infectious Disease Testing, by Country, 2024-2031 (USD Million)
Table 136 Transplant Diagnostics Market For Histocompatibility Testing, by Region, 2024-2031 (USD Million)
Table 137 North America: Transplant Diagnostics Market For Histocompatibility Testing, by Country, 2024-2031 (USD Million)
Table 138 Europe: Transplant Diagnostics Market For Histocompatibility Testing, by Country, 2024-2031 (USD Million)
Table 139 Asia-Pacific: Transplant Diagnostics Market For Histocompatibility Testing, by Country, 2024-2031 (USD Million)
Table 140 Latin America: Transplant Diagnostics Market For Histocompatibility Testing, by Country, 2024-2031 (USD Million)
Table 141 Middle East & Africa: Transplant Diagnostics Market For Histocompatibility Testing, by Country, 2024-2031 (USD Million)
Table 142 Transplant Diagnostics Market For Blood Profiling, by Region, 2024-2031 (USD Million)
Table 143 North America: Transplant Diagnostics Market For Blood Profiling, by Country, 2024-2031 (USD Million)
Table 144 Europe: Transplant Diagnostics Market For Blood Profiling, by Country, 2024-2031 (USD Million)
Table 145 Asia-Pacific: Transplant Diagnostics Market For Blood Profiling, by Country, 2024-2031 (USD Million)
Table 146 Latin America: Transplant Diagnostics Market For Blood Profiling, by Country, 2024-2031 (USD Million)
Table 147 Middle East & Africa: Transplant Diagnostics Market For Blood Profiling, by Country, 2024-2031 (USD Million)
Table 148 Transplant Diagnostics Market For Post-Transplantation Diagnostics, by Region, 2024-2031 (USD Million)
Table 149 North America: Transplant Diagnostics Market For Post-Transplantation Diagnostics, by Country, 2024-2031 (USD Million)
Table 150 Europe: Transplant Diagnostics Market For Post-Transplantation Diagnostics, by Country, 2024-2031 (USD Million)
Table 151 Asia-Pacific: Transplant Diagnostics Market For Post-Transplantation Diagnostics, by Country, 2024-2031 (USD Million)
Table 152 Latin America: Transplant Diagnostics Market For Post-Transplantation Diagnostics, by Country, 2024-2031 (USD Million)
Table 153 Middle East & Africa: Transplant Diagnostics Market For Post-Transplantation Diagnostics, by Country, 2024-2031 (USD Million)
Table 154 Transplant Diagnostics Market For Research Applications, by Region, 2024-2031 (USD Million)
Table 155 North America: Transplant Diagnostics Market For Research Applications, by Country, 2024-2031 (USD Million)
Table 156 Europe: Transplant Diagnostics Market For Research Applications, by Country, 2024-2031 (USD Million)
Table 157 Asia-Pacific: Transplant Diagnostics Market For Research Applications, by Country, 2024-2031 (USD Million)
Table 158 Latin America: Transplant Diagnostics Market For Research Applications, by Country, 2024-2031 (USD Million)
Table 159 Middle East & Africa: Transplant Diagnostics Market For Research Applications, by Country, 2024-2031 (USD Million)
Table 160 Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 161 Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 162 Transplant Diagnostics Market For Solid Organ Transplantation, by Region, 2024-2031 (USD Million)
Table 163 North America: Transplant Diagnostics Market For Solid Organ Transplantation, by Country, 2024-2031 (USD Million)
Table 164 Europe: Transplant Diagnostics Market For Solid Organ Transplantation, by Country, 2024-2031 (USD Million)
Table 165 Asia-Pacific: Transplant Diagnostics Market For Solid Organ Transplantation, by Country, 2024-2031 (USD Million)
Table 166 Latin America: Transplant Diagnostics Market For Solid Organ Transplantation, by Country, 2024-2031 (USD Million)
Table 167 Middle East & Africa: Transplant Diagnostics Market For Solid Organ Transplantation, by Country, 2024-2031 (USD Million)
Table 168 Transplant Diagnostics Market For Kidney Transplantation, by Region, 2024-2031 (USD Million)
Table 169 North America: Transplant Diagnostics Market For Kidney Transplantation, by Country, 2024-2031 (USD Million)
Table 170 Europe: Transplant Diagnostics Market For Kidney Transplantation, by Country, 2024-2031 (USD Million)
Table 171 Asia-Pacific: Transplant Diagnostics Market For Kidney Transplantation, by Country, 2024-2031 (USD Million)
Table 172 Latin America: Transplant Diagnostics Market For Kidney Transplantation, by Country, 2024-2031 (USD Million)
Table 173 Middle East & Africa: Transplant Diagnostics Market For Kidney Transplantation, by Country, 2024-2031 (USD Million)
Table 174 Transplant Diagnostics Market For Liver Transplantation, by Region, 2024-2031 (USD Million)
Table 175 North America: Transplant Diagnostics Market For Liver Transplantation, by Country, 2024-2031 (USD Million)
Table 176 Europe: Transplant Diagnostics Market For Liver Transplantation, by Country, 2024-2031 (USD Million)
Table 177 Asia-Pacific: Transplant Diagnostics Market For Liver Transplantation, by Country, 2024-2031 (USD Million)
Table 178 Latin America: Transplant Diagnostics Market For Liver Transplantation, by Country, 2024-2031 (USD Million)
Table 179 Middle East & Africa: Transplant Diagnostics Market For Liver Transplantation, by Country, 2024-2031 (USD Million)
Table 180 Transplant Diagnostics Market For Lung Transplantation, by Region, 2024-2031 (USD Million)
Table 181 North America: Transplant Diagnostics Market For Lung Transplantation, by Country, 2024-2031 (USD Million)
Table 182 Europe: Transplant Diagnostics Market For Lung Transplantation, by Country, 2024-2031 (USD Million)
Table 183 Asia-Pacific: Transplant Diagnostics Market For Lung Transplantation, by Country, 2024-2031 (USD Million)
Table 184 Latin America: Transplant Diagnostics Market For Lung Transplantation, by Country, 2024-2031 (USD Million)
Table 185 Middle East & Africa: Transplant Diagnostics Market For Lung Transplantation, by Country, 2024-2031 (USD Million)
Table 186 Transplant Diagnostics Market For Heart Transplantation, by Region, 2024-2031 (USD Million)
Table 187 North America: Transplant Diagnostics Market For Heart Transplantation, by Country, 2024-2031 (USD Million)
Table 188 Europe: Transplant Diagnostics Market For Heart Transplantation, by Country, 2024-2031 (USD Million)
Table 189 Asia-Pacific: Transplant Diagnostics Market For Heart Transplantation, by Country, 2024-2031 (USD Million)
Table 190 Latin America: Transplant Diagnostics Market For Heart Transplantation, by Country, 2024-2031 (USD Million)
Table 191 Middle East & Africa: Transplant Diagnostics Market For Heart Transplantation, by Country, 2024-2031 (USD Million)
Table 192 Transplant Diagnostics Market For Pancreas Transplantation, by Region, 2024-2031 (USD Million)
Table 193 North America: Transplant Diagnostics Market For Pancreas Transplantation, by Country, 2024-2031 (USD Million)
Table 194 Europe: Transplant Diagnostics Market For Pancreas Transplantation, by Country, 2024-2031 (USD Million)
Table 195 Asia-Pacific: Transplant Diagnostics Market For Pancreas Transplantation, by Country, 2024-2031 (USD Million)
Table 196 Latin America: Transplant Diagnostics Market For Pancreas Transplantation, by Country, 2024-2031 (USD Million)
Table 197 Middle East & Africa: Transplant Diagnostics Market For Pancreas Transplantation, by Country, 2024-2031 (USD Million)
Table 198 Transplant Diagnostics Market For Other Solid Organ Transplantation, by Region, 2024-2031 (USD Million)
Table 199 North America: Transplant Diagnostics Market For Other Solid Organ Transplantation, by Country, 2024-2031 (USD Million)
Table 200 Europe: Transplant Diagnostics Market For Other Solid Organ Transplantation, by Country, 2024-2031 (USD Million)
Table 201 Asia-Pacific: Transplant Diagnostics Market For Other Solid Organ Transplantation, by Country, 2024-2031 (USD Million)
Table 202 Latin America: Transplant Diagnostics Market For Other Solid Organ Transplantation, by Country, 2024-2031 (USD Million)
Table 203 Middle East & Africa: Transplant Diagnostics Market For Other Solid Organ Transplantation, by Country, 2024-2031 (USD Million)
Table 204 Transplant Diagnostics Market For Stem Cell Transplantation, by Region, 2024-2031 (USD Million)
Table 205 North America: Transplant Diagnostics Market For Stem Cell Transplantation, by Country, 2024-2031 (USD Million)
Table 206 Europe: Transplant Diagnostics Market For Stem Cell Transplantation, by Country, 2024-2031 (USD Million)
Table 207 Asia-Pacific: Transplant Diagnostics Market For Stem Cell Transplantation, by Country, 2024-2031 (USD Million)
Table 208 Latin America: Transplant Diagnostics Market For Stem Cell Transplantation, by Country, 2024-2031 (USD Million)
Table 209 Middle East & Africa: Transplant Diagnostics Market For Stem Cell Transplantation, by Country, 2024-2031 (USD Million)
Table 210 Transplant Diagnostics Market For Soft Tissue Transplantation, by Region, 2024-2031 (USD Million)
Table 211 North America: Transplant Diagnostics Market For Soft Tissue Transplantation, by Country, 2024-2031 (USD Million)
Table 212 Europe: Transplant Diagnostics Market For Soft Tissue Transplantation, by Country, 2024-2031 (USD Million)
Table 213 Asia-Pacific: Transplant Diagnostics Market For Soft Tissue Transplantation, by Country, 2024-2031 (USD Million)
Table 214 Latin America: Transplant Diagnostics Market For Soft Tissue Transplantation, by Country, 2024-2031 (USD Million)
Table 215 Middle East & Africa: Transplant Diagnostics Market For Soft Tissue Transplantation, by Country, 2024-2031 (USD Million)
Table 216 Transplant Diagnostics Market For Bone Marrow Transplantation, by Region, 2024-2031 (USD Million)
Table 217 North America: Transplant Diagnostics Market For Bone Marrow Transplantation, by Country, 2024-2031 (USD Million)
Table 218 Europe: Transplant Diagnostics Market For Bone Marrow Transplantation, by Country, 2024-2031 (USD Million)
Table 219 Asia-Pacific: Transplant Diagnostics Market For Bone Marrow Transplantation, by Country, 2024-2031 (USD Million)
Table 220 Latin America: Transplant Diagnostics Market For Bone Marrow Transplantation, by Country, 2024-2031 (USD Million)
Table 221 Middle East & Africa: Transplant Diagnostics Market For Bone Marrow Transplantation, by Country, 2024-2031 (USD Million)
Table 222 Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 223 Transplant Diagnostics Market For Independent Reference Laboratories, by Region, 2024-2031 (USD Million)
Table 224 North America: Transplant Diagnostics Market For Independent Reference Laboratories, by Country, 2024-2031 (USD Million)
Table 225 Europe: Transplant Diagnostics Market For Independent Reference Laboratories, by Country, 2024-2031 (USD Million)
Table 226 Asia-Pacific: Transplant Diagnostics Market For Independent Reference Laboratories, by Country, 2024-2031 (USD Million)
Table 227 Latin America: Transplant Diagnostics Market For Independent Reference Laboratories, by Country, 2024-2031 (USD Million)
Table 228 Middle East & Africa: Transplant Diagnostics Market For Independent Reference Laboratories, by Country, 2024-2031 (USD Million)
Table 229 Transplant Diagnostics Market For Hospitals & Transplant Centers, by Region, 2024-2031 (USD Million)
Table 230 North America: Transplant Diagnostics Market For Hospitals & Transplant Centers, by Country, 2024-2031 (USD Million)
Table 231 Europe: Transplant Diagnostics Market For Hospitals & Transplant Centers, by Country, 2024-2031 (USD Million)
Table 232 Asia-Pacific: Transplant Diagnostics Market For Hospitals & Transplant Centers, by Country, 2024-2031 (USD Million)
Table 233 Latin America: Transplant Diagnostics Market For Hospitals & Transplant Centers, by Country, 2024-2031 (USD Million)
Table 234 Middle East & Africa: Transplant Diagnostics Market For Hospitals & Transplant Centers, by Country, 2024-2031 (USD Million)
Table 235 Transplant Diagnostics Market For Research Laboratories & Academic Institutes, by Region, 2024-2031 (USD Million)
Table 236 North America: Transplant Diagnostics Market For Research Laboratories & Academic Institutes, by Country, 2024-2031 (USD Million)
Table 237 Europe: Transplant Diagnostics Market For Research Laboratories & Academic Institutes, by Country, 2024-2031 (USD Million)
Table 238 Asia-Pacific: Transplant Diagnostics Market For Research Laboratories & Academic Institutes, by Country, 2024-2031 (USD Million)
Table 239 Latin America: Transplant Diagnostics Market For Research Laboratories & Academic Institutes, by Country, 2024-2031 (USD Million)
Table 240 Middle East & Africa: Transplant Diagnostics Market For Research Laboratories & Academic Institutes, by Country, 2024-2031 (USD Million)
Table 241 Transplant Diagnostics, by Region, 2024-2031 (USD Million)
Table 242 North America: Macroeconomic Indicators
Table 243 North America: Transplant Diagnostics Market, by Country, 2024-2031 (USD Million)
Table 244 North America: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 245 North America: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 246 North America: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 247 North America: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 248 North America: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 249 North America: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 250 North America: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 251 North America: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 252 North America: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 253 North America: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 254 North America: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 255 US: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 256 US: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 257 US: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 258 US: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 259 US: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 260 US: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 261 US: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 262 US: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 263 US: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 264 US: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 265 US: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 266 Canada: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 267 Canada: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 268 Canada: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 269 Canada: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 270 Canada: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 271 Canada: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 272 Canada: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 273 Canada: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 274 Canada: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 275 Canada: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 276 Canada: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 277 Macroeconomic Indicators For Europe
Table 278 Europe: Transplant Diagnostics Market, by Country, 2024-2031 (USD Million)
Table 279 Europe: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 280 Europe: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 281 Europe: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 282 Europe: Transplant Diagnostics Market For Pcr-Based Mole
Table 285 Europe: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 286 Europe: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 287 Europe: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 288 Europe: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 289 Europe: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 290 Germany: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 291 Germany: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 292 Germany: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 293 Germany: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 294 Germany: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 295 Germany: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 296 Germany: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 297 Germany: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 298 Germany: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 299 Germany: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 300 Germany: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 301 UK: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 302 UK: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 303 UK: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 304 UK: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 305 UK: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 306 UK: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 307 UK: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 308 UK: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 309 UK: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 310 UK: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 311 UK: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 312 France: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 313 France: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 314 France: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 315 France: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 316 France: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 317 France: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 318 France: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 319 France: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 320 France: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 321 France: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 322 France: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 323 Italy: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 324 Italy: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 325 Italy: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 326 Italy: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 327 Italy: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 328 Italy: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 329 Italy: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 330 Italy: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 331 Italy: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 332 Italy: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 333 Italy: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 334 Spain: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 335 Spain: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 336 Spain: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 337 Spain: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 338 Spain: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 339 Spain: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 340 Spain: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 341 Spain: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 342 Spain: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 343 Spain: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 344 Spain: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 345 Rest of Europe: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 346 Rest of Europe: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 347 Rest of Europe: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 348 Rest of Europe: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 349 Rest of Europe: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 350 Rest of Europe: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 351 Rest of Europe: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 352 Rest of Europe: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 353 Rest of Europe: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 354 Rest of Europe: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 355 Rest of Europe: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 356 Macroeconomic Indicators For Asia-Pacific
Table 357 Asia-Pacific: Transplant Diagnostics Market, by Country, 2024-2031 (USD Million)
Table 358 Asia-Pacific: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 359 Asia-Pacific: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 360 Asia-Pacific: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 361 Asia-Pacific: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 362 Asia-Pacific: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 363 Asia-Pacific: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 364 Asia-Pacific: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 365 Asia-Pacific: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 366 Asia-Pacific: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 367 Asia-Pacific: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 368 Asia-Pacific: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 369 China: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 370 China: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 371 China: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 372 China: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 373 China: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 374 China: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 375 China: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 376 China: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 377 China: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 378 China: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 379 China: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 380 Japan: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 381 Japan: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 382 Japan: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 383 Japan: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 384 Japan: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 385 Japan: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 386 Japan: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 387 Japan: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 388 Japan: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 389 Japan: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 390 Japan: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 391 India: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 392 India: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 393 India: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 394 India: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 395 India: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 396 India: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 397 India: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 398 India: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 399 India: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 400 India: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 401 India: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 402 Australia: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 403 Australia: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 404 Australia: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 405 Australia: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 406 Australia: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 407 Australia: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 408 Australia: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 409 Australia: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 410 Australia: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 411 Australia: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 412 Australia: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 413 South Korea: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 414 South Korea: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 415 South Korea: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 416 South Korea: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 417 South Korea: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 418 South Korea: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 419 South Korea: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 420 South Korea: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 421 South Korea: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 422 South Korea: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 423 South Korea: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 424 Rest of Asia-Pacific: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 425 Rest of Asia-Pacific: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 426 Rest of Asia-Pacific: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 427 Rest of Asia-Pacific: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 428 Rest of Asia-Pacific: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 429 Rest of Asia-Pacific: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 430 Rest of Asia-Pacific: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 431 Rest of Asia-Pacific: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 432 Rest of Asia-Pacific: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 433 Rest of Asia-Pacific: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 434 Rest of Asia-Pacific: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 435 Macroeconomic Indicators For Latin America
Table 436 Latin America: Transplant Diagnostics Market, by Country, 2024-2031 (USD Million)
Table 437 Latin America: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 438 Latin America: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 439 Latin America: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 440 Latin America: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 441 Latin America: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 442 Latin America: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 443 Latin America: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 444 Latin America: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 445 Latin America: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 446 Latin America: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 447 Latin America: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 448 Brazil: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 449 Brazil: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 450 Brazil: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 451 Brazil: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 452 Brazil: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 453 Brazil: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 454 Brazil: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 455 Brazil: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 456 Brazil: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 457 Brazil: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 458 Brazil: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 459 Mexico: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 460 Mexico: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 461 Mexico: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 462 Mexico: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 463 Mexico: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 464 Mexico: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 465 Mexico: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 466 Mexico: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 467 Mexico: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 468 Mexico: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 469 Mexico: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 470 Rest of Latin America: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 471 Rest of Latin America: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 472 Rest of Latin America: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 473 Rest of Latin America: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 474 Rest of Latin America: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 475 Rest of Latin America: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 476 Rest of Latin America: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 477 Rest of Latin America: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 478 Rest of Latin America: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 479 Rest of Latin America: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 480 Rest of Latin America: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 481 Macroeconomic Indicators For Middle East & Africa
Table 482 Middle East & Africa: Transplant Diagnostics Market, by Country, 2024-2031 (USD Million)
Table 483 Middle East & Africa: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 484 Middle East & Africa: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 485 Middle East & Africa: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 486 Middle East & Africa: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 487 Middle East & Africa: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 488 Middle East & Africa: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 489 Middle East & Africa: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 490 Middle East & Africa: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 491 Middle East & Africa: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 492 Middle East & Africa: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 493 Middle East & Africa: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 494 UAE: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 495 UAE: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 496 UAE: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 497 UAE: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 498 UAE: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 499 UAE: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 500 UAE: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 501 UAE: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 502 UAE: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 503 UAE: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 504 UAE: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 505 Saudi Arabia: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 506 Saudi Arabia: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 507 Saudi Arabia: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 508 Saudi Arabia: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 509 Saudi Arabia: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 510 Saudi Arabia: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 511 Saudi Arabia: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 512 Saudi Arabia: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 513 Saudi Arabia: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 514 Saudi Arabia: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 515 Saudi Arabia: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 516 Rest of Middle East & Africa: Transplant Diagnostics Market, by Product & Service, 2024-2031 (USD Million)
Table 517 Rest of Middle East & Africa: Transplant Diagnostics Market, by Technology, 2024-2031 (USD Million)
Table 518 Rest of Middle East & Africa: Transplant Diagnostics Market For Molecular Assays, by Type, 2024-2031 (USD Million)
Table 519 Rest of Middle East & Africa: Transplant Diagnostics Market For Pcr-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 520 Rest of Middle East & Africa: Transplant Diagnostics Market For Sequencing-Based Molecular Assays, by Type, 2024-2031 (USD Million)
Table 521 Rest of Middle East & Africa: Transplant Diagnostics Market, by Application, 2024-2031 (USD Million)
Table 522 Rest of Middle East & Africa: Transplant Diagnostics Market For Diagnostic Applications, by Type, 2024-2031 (USD Million)
Table 523 Rest of Middle East & Africa: Transplant Diagnostics Market For Pre-Transplantation Diagnostics, by Type, 2024-2031 (USD Million)
Table 524 Rest of Middle East & Africa: Transplant Diagnostics Market, by Type, 2024-2031 (USD Million)
Table 525 Rest of Middle East & Africa: Transplant Diagnostics Market For Solid Organ Transplantation, by Type, 2024-2031 (USD Million)
Table 526 Rest of Middle East & Africa: Transplant Diagnostics Market, by End User, 2024-2031 (USD Million)
Table 527 US: Heart, Liver, and Lung Transplants Market, by Type, 2024-2031 (In Thousand)
Table 528 Overview of Strategies Deployed by Key Companies in Transplant Diagnostics Market, January 2023-April 2026
Table 529 Transplant Diagnostics Market: Degree of Competition
Table 530 Transplant Diagnostics Market: Region Footprint
Table 531 Transplant Diagnostics Market: Product & Service Footprint
Table 532 Transplant Diagnostics Market: Application Footprint
Table 533 Transplant Diagnostics Market: End-User Footprint
Table 534 Transplant Diagnostics Market: Detailed List of Key Startups/SMEs
Table 535 Transplant Diagnostics Market: Competitive Benchmarking of Startups/SMEs (1/2)
Table 536 Transplant Diagnostics Market: Competitive Benchmarking of Startups/SMEs (2/2)
Table 537 Transplant Diagnostics Market: Product/Service Launches & Approvals, January 2023-April 2026
Table 538 Transplant Diagnostics Market: Deals, January 2023-April 2026
Table 539 Transplant Diagnostics Market: Expansion, January 2023-April 2026
Table 540 Thermo Fisher Scientific Inc.: Company Overview
Table 541 Thermo Fisher Scientific Inc.: Products Offered
Table 542 Thermo Fisher Scientific Inc.: Product & Service Launches, January 2023-April 2026
Table 543 Thermo Fisher Scientific Inc.: Deals, January 2023-April 2026
Table 544 Thermo Fisher Scientific Inc.: Expansions, January 2022-April 2025
Table 545 F. Hoffmann-La Roche Ltd.: Company Overview
Table 546 F. Hoffmann-La Roche Ltd.: Products Offered
Table 547 F. Hoffmann-La Roche Ltd.: Product Launches & Approvals, January 2023-April 2026
Table 548 F. Hoffmann-La Roche Ltd.: Deals, January 2023-April 2026
Table 549 Bio-Rad Laboratories, Inc.: Company Overview
Table 550 Bio-Rad Laboratories, Inc.: Products Offered
Table 551 Bio-Rad Laboratories, Inc.: Product Launches, January 2023-April 2026
Table 552 Bio-Rad Laboratories, Inc.: Deals, January 2023-April 2026
Table 553 Qiagen N.V.: Company Overview
Table 554 Qiagen N.V.: Products Offered
Table 555 Qiagen N.V.: Product Launches & Approvals, January 2023-April 2026
Table 556 Qiagen N.V.: Deals, January 2023-April 2026
Table 557 Biomérieux: Company Overview
Table 558 Biomérieux: Products Offered
Table 559 Biomérieux: Product Launches & Approvals, January 2023-April 2026
Table 560 Biomérieux: Deals, January 2023-April 2026
Table 561 Illumina, Inc.: Company Overview
Table 562 Illumina, Inc.: Products Offered
Table 563 Illumina, Inc.: Deals, January 2023-April 2026
Table 564 Becton, Dickinson and Company: Company Overview
Table 565 Becton, Dickinson and Company: Products Offered
Table 566 Becton, Dickinson and Company: Deals, January 2023-April 2026
Table 567 Caredx, Inc.: Company Overview
Table 568 Caredx, Inc.: Products Offered
Table 569 Caredx, Inc.: Product Launches, January 2023-April 2026
Table 570 Caredx, Inc.: Deals, January 2023-April 2026
Table 571 Diasorin S.P.A.: Company Overview
Table 572 Diasorin S.P.A.: Products Offered
Table 573 Diasorin S.P.A.: Product Launches, January 2023-April 2026
Table 574 Diasorin S.P.A.: Deals, January 2023-April 2026
Table 575 Werfen: Company Overview
Table 576 Werfen: Products Offered
Table 577 Werfen: Product Launches, January 2023-April 2026
Table 578 Werfen: Deals, January 2023-April 2026
Table 579 Merck Kgaa: Company Overview
Table 580 Merck Kgaa: Products Offered
Table 581 Merck Kgaa: Deals, January 2023-April 2026
Table 582 Merck Kgaa: Expansions, January 2023-April 2026
Table 583 Hologic, Inc.: Company Overview
Table 584 Hologic, Inc.: Products Offered
Table 585 Eurobio Scientific: Company Overview
Table 586 Biofortuna Limited: Company Overview
Table 587 Bag Diagnostics GmbH: Company Overview
Table 588 Fujirebio: Company Overview
Table 589 Histogenetics LLC: Company Overview
Table 590 Pacbio: Company Overview
Table 591 Tbg Biotechnology Corp: Company Overview
Table 592 Scisco Genetics, Inc.: Company Overview
Table 593 Inno-Train Diagnostik GmbH: Company Overview
Table 594 Bionobis: Company Overview
Table 595 Takara Bio Inc.: Company Overview
Table 596 Krishgen Biosystems Private Limited: Company Overview
Table 597 Proimmune Ltd.: Company Overview
Table 598 Transplant Diagnostics Market: Risk Assessment

Figure 1 Transplant Diagnostics Market Segmentation & Regional Scope
Figure 2 Key Insights & Market Highlights
Figure 3 Global Transplant Diagnostics Market, 2024-2031
Figure 4 Major Strategies Adopted by Key Players in Transplant Diagnostics Market, 2023-2025
Figure 5 Disruptive Trends Impacting Growth of Transplant Diagnostics Market
Figure 6 High-Growth Segments & Emerging Frontiers in Transplant Diagnostics Market, 2025
Figure 7 Asia-Pacific to Register Highest Growth During Forecast Period
Figure 8 Rising Cases of Infectious Diseases to Drive Market
Figure 9 Reagents & Consumables Segment to Dominate Market During Forecast Period
Figure 10 Molecular Assays Segment to Lead Market During Forecast Period
Figure 11 Diagnostic Applications Segment to Lead Market During Forecast Period
Figure 12 Solid Organ Transplantation Segment to Dominate Market During Forecast Period
Figure 13 Independent Reference Laboratories Segment to Lead Market During Forecast Period
Figure 14 Asia-Pacific to Register Highest Growth During Forecast Period
Figure 15 Transplant Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Transplant Diagnostics Market: Porter'S Five Forces Analysis
Figure 17 Transplant Diagnostics Market: Supply Chain Analysis
Figure 18 Transplant Diagnostics Market: Value Chain Analysis
Figure 19 Transplant Diagnostics Market: Ecosystem Analysis
Figure 20 Transplant Diagnostics Market: Trends & Disruptions Impacting Customers’ Businesses
Figure 21 Number of Deals & Funding Activities in Transplant Diagnostics Market
Figure 22 Patent Analysis For Transplant Diagnostics, January 2016-December 2025
Figure 23 Market Potential of AI in Transplant Diagnostics Market
Figure 24 Influence of Stakeholders On Buying Process, by Product & Service
Figure 25 Key Buying Criteria, by Product & Service
Figure 26 North America: Transplant Diagnostics Market Snapshot
Figure 27 Asia-Pacific: Transplant Diagnostics Market Snapshot
Figure 28 Revenue Analysis of Key Players in Transplant Diagnostics Market, 2023-2025 (USD Million)
Figure 29 Transplant Diagnostics Market Share Analysis, 2025 (Global)
Figure 30 Transplant Diagnostics Market: Company Evaluation Matrix (Key Players), 2025
Figure 31 Transplant Diagnostics Market: Company Footprint
Figure 32 Transplant Diagnostics Market: Company Evaluation Matrix (Startups/SMEs), 2025
Figure 33 Ev/EBITDA of Key Vendors
Figure 34 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 35 Transplant Diagnostics Market: Brand/Product Comparison For Transplant Instruments
Figure 36 Thermo Fisher Scientific Inc.: Company Snapshot (2025)
Figure 37 F. Hoffmann-La Roche Ltd.: Company Snapshot (2025)
Figure 38 Bio-Rad Laboratories, Inc.: Company Snapshot (2025)
Figure 39 Qiagen N.V.: Company Snapshot (2025)
Figure 40 Biomérieux: Company Snapshot (2025)
Figure 41 Illumina, Inc.: Company Snapshot (2025)
Figure 42 Becton, Dickinson and Company: Company Snapshot (2025)
Figure 43 Caredx, Inc.: Company Snapshot (2025)
Figure 44 Diasorin S.P.A.: Company Snapshot (2025)
Figure 45 Werfen: Company Snapshot (2025)
Figure 46 Merck Kgaa: Company Snapshot (2025)
Figure 47 Hologic, Inc.: Company Snapshot (2025)
Figure 48 Research Design
Figure 49 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 50 Top-Down Approach
Figure 51 Data Triangulation